Claritev Current Ratio 2019-2025 | CTEV

Claritev current ratio from 2019 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Claritev Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.19B $0.18B 1.02
2024-12-31 $0.18B $0.21B 0.82
2024-09-30 $0.21B $0.20B 1.05
2024-06-30 $0.19B $0.18B 1.06
2024-03-31 $0.19B $0.19B 0.98
2023-12-31 $0.19B $0.17B 1.16
2023-09-30 $0.21B $0.17B 1.23
2023-06-30 $0.21B $0.15B 1.42
2023-03-31 $0.37B $0.16B 2.39
2022-12-31 $0.45B $0.18B 2.54
2022-09-30 $0.53B $0.23B 2.30
2022-06-30 $0.47B $0.15B 3.17
2022-03-31 $0.46B $0.20B 2.25
2021-12-31 $0.32B $0.14B 2.25
2021-09-30 $0.31B $0.17B 1.83
2021-06-30 $0.28B $0.11B 2.52
2021-03-31 $0.21B $0.22B 0.98
2020-12-31 $0.21B $0.11B 1.86
2020-09-30 $0.00B $0.01B 0.38
2020-06-30 $0.00B $0.00B 1.71
2020-03-31 $0.00B $0.00B 9.65
2019-12-31 $0.00B 0.00
2018-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.405B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.242B 54.20
Hims & Hers Health (HIMS) United States $14.325B 148.84
Tempus AI (TEM) United States $11.867B 0.00
Inspire Medical Systems (INSP) United States $4.712B 73.62
IRhythm Technologies (IRTC) United States $4.463B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.134B 11.90
Clover Health Investments (CLOV) United States $1.737B 0.00
Schrodinger (SDGR) United States $1.735B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.312B 23.14
Azenta (AZTA) United States $1.277B 59.36
10x Genomics (TXG) United States $1.180B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.589B 0.00
Talkspace (TALK) United States $0.514B 153.50
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.433B 0.00
TruBridge (TBRG) United States $0.375B 831.67
Health Catalyst (HCAT) United States $0.299B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.208B 0.00
Nyxoah SA (NYXH) Belgium $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.156B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
American Well (AMWL) United States $0.119B 0.00
MDxHealth SA (MDXH) Belgium $0.084B 0.00
CareCloud (CCLD) United States $0.084B 3.19
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
Outset Medical (OM) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00